prostate cancer

2019 ASCO ® Annual Meeting; #ASCO19
June 2, 2019 · Monika Sharda, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care. Read More >>
Genitourinary Cancers Symposium
February 11, 2019 · Greg Guthrie, ASCO Staff
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer. Read More >>
January 17, 2019 · Carol Michaels, MBA, ACE, ACSM
Exercise can greatly improve the physical and mental health of men with prostate cancer. Exercise specialist Carol Michaels shares what the benefits are and how to start a program that’s right for you. Read More >>
January 8, 2019 · Greg Guthrie, ASCO staff
In this podcast, Dr. Brian Rini and Dr. Jorge Garcia discuss the latest research in genitourinary cancers presented at the 2018 ESMO Congress. Read More >>
2018 ASCO Annual Meeting; #ASCO18
June 1, 2018 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include the effects of geriatric assessment on patient-doctor communication, treatments for advanced prostate cancer that may work better in black men, the possibility that women are undertreated for head and neck cancer, and a comparison of treatment costs for colorectal cancer between the U.S. and Canada. Read More >>

Pages